Solventum Corporation
SOLV Healthcare Medical Instruments & Supplies
Solventum Corporation’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.86% from fiscal 2024. In the quarter to June 2026, revenue grew 2.22%, EPS grew 1.92%, free cash flow grew 144.1% and total debt fell 32.4%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for three consecutive years; insiders bought in the last twelve months.
Follow SOLV
Solventum Corporation (SOLV) Return on invested capital
Solventum Corporation's return on invested capital over the twelve months to 30 June 2026 was 13.4%, down 1.4 percentage points from fiscal 2025 (14.8%). That is above the Medical Instruments & Supplies industry median of 0.00% and above the Healthcare sector median of 0.00%.
Return on invested capital, annual
Embed this chart
Annual newest first
| Period | Return on invested capital | Change (points) |
|---|---|---|
| FY2025 | 14.8% | 8.47 |
| FY2024 | 6.34% | (2.88) |
| FY2023 | 9.22% | 9.22 |
| FY2022 | 0.00% | — |
Return on invested capital against peers
| Company | Return on invested capital |
|---|---|
| WST West Pharmaceutical Services, Inc. compare | 15.4% |
| SOLV Solventum Corporation | 13.4% |
| ALGN Align Technology, Inc. compare | 10.9% |
| ATR AptarGroup, Inc. compare | 7.82% |
| COO The Cooper Companies, Inc. compare | 3.17% |
| ALC Alcon compare | 2.38% |
| RGEN Repligen Corporation compare | 2.18% |
| BAX Baxter International Inc. compare | −1.27% |
| AVTR Avantor, Inc. compare | −2.09% |
| Medical Instruments & Supplies industry median | 0.00% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Return on invested capital is
Return on Invested Capital shows how much after-tax operating profit a company earns on the money its lenders and shareholders have put in.
TTM: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) (latest quarter) + Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter) − Cash & Short Term Investments (latest quarter)); Annual: (Operating Income × 0.625) ÷ (Shareholders Equity (Total) + Long Term Debt (Total) + Current Part of Debt − Cash & Short Term Investments)
More on SOLV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement